Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Chemically Synthesized Medicines
100.0
%
| 14 | 100.0 % | 27 | 100.0 % | +86.52% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United Kingdom
100.0
%
| 14 | 100.0 % | 27 | 100.0 % | +86.52% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kevin Lee
CEO | Chief Executive Officer | 55 | 01/15/01 |
Alethia Young
DFI | Director of Finance/CFO | 45 | 17/23/17 |
Alistair Milnes
COO | Chief Operating Officer | 50 | 01/21/01 |
Michael Skynner
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/16/01 |
Nicholas Keen
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/17/01 |
David Borah
IRC | Investor Relations Contact | - | 01/21/01 |
Jennifer Perry
PRN | Corporate Officer/Principal | - | - |
Travis Thompson
AUD | Comptroller/Controller/Auditor | - | 01/18/01 |
Zafar Qadir
LAW | General Counsel | - | 23/20/23 |
Santiago Arroyo
PRN | Corporate Officer/Principal | 64 | 31/23/31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Pierre Legault
CHM | Chairman | 63 | 18/19/18 |
Director/Board Member | 61 | 17/21/17 | |
Richard Kender
BRD | Director/Board Member | 68 | 24/19/24 |
Janice Bourque
BRD | Director/Board Member | 67 | 18/19/18 |
Gregory Winter
FOU | Founder | 73 | 01/09/01 |
Kevin Lee
CEO | Chief Executive Officer | 55 | 01/15/01 |
Stephen Sands
BRD | Director/Board Member | 67 | 20/02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 37,880,303 | 4,333,333 ( 11.44 %) | 0 | 11.44 % |
Company contact information
Bicycle Therapeutics Plc
Granta Park Great Abington Portway Building
CB21 6GS, Cambridge
+44 1223 261 503
http://bicycletherapeutics.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |